Search
Tenocyclidine
go.drugbank.com/drugs/DB01520IllicitInvestigationalTenocyclidine (TCP, thienyl cyclohexylpiperidine) is a dissociative anesthetic drug with stimulant and hallucinogenic effects.
Categories: Compounds used in a research, industrial, or household settingLamifiban
go.drugbank.com/drugs/DB20451ExperimentalLamifiban has a monoisotopic molecular weight of 468.2 Da. … Lamifiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lamifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).
Lotrafiban
go.drugbank.com/drugs/DB20872ExperimentalLotrafiban has a monoisotopic molecular weight of 428.24 Da. … Lotrafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lotrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).
Tanogitran
go.drugbank.com/drugs/DB21367InvestigationalTanogitran has a monoisotopic molecular weight of 477.25 Da. … Tanogitran is a small molecule drug.
Masofaniten
go.drugbank.com/drugs/DB21580InvestigationalMasofaniten has a monoisotopic molecular weight of 534.09 Da. … Masofaniten is a small molecule drug.
Pixavir marboxil
go.drugbank.com/drugs/DB21589ExperimentalPixavir marboxil has a monoisotopic molecular weight of 540.12 Da. … Pixavir marboxil is a small molecule drug. The usage of the INN stem '-xavir' in the name indicates that Pixavir marboxil is a influenza CAP-dependent endonuclease inhibitor.
Crelosidenib
go.drugbank.com/drugs/DB21642InvestigationalCrelosidenib has a monoisotopic molecular weight of 504.28 Da. … Crelosidenib is a small molecule drug.
Rosabulin
go.drugbank.com/drugs/DB20161InvestigationalRosabulin has a monoisotopic molecular weight of 400.1 Da. … Rosabulin is a small molecule drug. Rosabulin is under investigation in clinical trial NCT00276913 (A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors).
Lunsotogene parvec
go.drugbank.com/drugs/DB18278ApprovedInvestigationalIt is the first gene therapy to be approved under the Commissioner's National Priority Voucher (CNPV) pilot and represents one of the fastest BLA approvals in modern history, with a time between filing … [L56135,L56136] This landmark decision followed designations as a Regenerative Medicine Advanced Therapy (RMAT) and Fast Track, marking the first-ever gene therapy approved to restore a neurosensory function
Bulevirtide
go.drugbank.com/drugs/DB15248ApprovedInvestigational[A226305] Bulevirtide, also known as Hepcludex, is a first-in-class entry inhibitor for the treatment of chronic Hepatitis D infection developed by MYR Pharmaceuticals, now part of Gilead. … potentially beneficial synergistic effects in treating chronic Hepatitis D, bulevirtide is also under investigation in clinical trial NCT03852433 (Phase 2b Study of Bulevirtide With [Peginterferon Alfa-2a